Bicuspid/Mitral Stenosis Strokes 
DAIC
MARCH 4, 2025
each year, according to the American Heart Association 2025 Heart Disease and Stroke Statistical Update. Key symptoms of aortic stenosis include: Chest pain Shortness of breath Dizziness or fainting Fatigue Rapid or irregular heartbeat Gender Disparities Studies have shown that women and men experience heart valve disease differently.
All About Cardiovascular System and Disorders
APRIL 1, 2024
Transcript of the video: Closure line of aortic valve on M-Mode echocardiogram, is seen as central line, while in bicuspid aortic valve, it is an eccentric closure, nearer to one of the walls of the aorta. That is an important feature of bicuspid aortic valve on M-Mode echocardiogram. So this is a premature beat. is the normal range.
Circulation: Cardiovascular Interventions
OCTOBER 17, 2023
BACKGROUND:Data concerning the outcomes of transcatheter aortic valve replacement in type 0 bicuspid aortic stenosis (AS) are scarce. Poverall=0.099) and all stroke (30 days: 1.0% Ascending aortic diameter was the single predictor of 1-year mortality in type 0 bicuspid patients (hazard ratio, 1.59 [95% CI, 1.03–2.44];P=0.035).
The British Journal of Cardiology
FEBRUARY 20, 2024
Patients with bicuspid aortic valves (BAV) are predisposed to the development of aortic stenosis. No significant differences were seen with other explored outcomes, including 30-day/mid-term mortality, stroke, acute kidney injury, major vascular complications, paravalvular leak, and conduction abnormalities. to 4.58, p=0.04).
DAIC
APRIL 11, 2024
All patients enrolled in the trial were eligible for either TAVR or SAVR and had similar characteristics in terms of the severity of aortic stenosis (narrowing of the valve which makes it harder for blood to flow efficiently) and a similar balance of risks and benefits expected with either type of procedure.
DAIC
FEBRUARY 15, 2024
Advances in Transcatheter Tricuspid Valve Technologies VIDEO: Tricuspid Device Clinical Trial Overview — Interview with Ori Ben-Yehuda, M.D.
DAIC
JUNE 7, 2024
The CoreValve and next-generation Evolut TAVR systems are used in TAVR procedures for patients with symptomatic severe aortic stenosis (AS), which are less invasive and typically result in a quicker recovery time than open heart surgery.i The natural history and rate of progression of aortic stenosis. Evolut vs. 10.6% Bax, Michael J.
Expert insights. Personalized for you.
52 
Let's personalize your content